Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1.65M | +28.9K | +11.15% | $56.94 | 288K | Jan 3, 2022 | Direct | F1, F2 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1.58M | +36.2K | +12.57% | $43.67 | 324K | Jan 3, 2022 | Direct | F1, F2 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1.09M | +21.1K | +6.51% | $51.83 | 345K | Jan 3, 2022 | Direct | F1, F2 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1.03M | +22K | +6.37% | $46.93 | 367K | Jan 3, 2022 | Direct | F1, F2 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Sale | -$6.79M | -108K | -29.46% | $62.76 | 259K | Jan 3, 2022 | Direct | F1, F2, F3 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $2.27M | +52.5K | +20.26% | $43.16 | 312K | Jan 4, 2022 | Direct | F1, F2 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1.65M | +42.5K | +13.63% | $38.96 | 354K | Jan 4, 2022 | Direct | F1, F2 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Sale | -$6.17M | -95K | -26.82% | $65.00 | 259K | Jan 4, 2022 | Direct | F1, F2 |
holding | ST | Ordinary Shares, par value EUR 0.01 per share | 89.8K | Jan 3, 2022 | By Irrevocable Family Trust | F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ST | Stock options to Buy | Options Exercise | $0 | -28.9K | -100% | $0.00* | 0 | Jan 3, 2022 | Ordinary Shares, par value EUR 0.01 per share | 28.9K | $56.94 | Direct | F1, F5 |
transaction | ST | Stock options to Buy | Options Exercise | $0 | -36.2K | -100% | $0.00* | 0 | Jan 3, 2022 | Ordinary Shares, par value EUR 0.01 per share | 36.2K | $43.67 | Direct | F1, F6 |
transaction | ST | Stock options to Buy | Options Exercise | $0 | -21.1K | -75% | $0.00 | 7.03K | Jan 3, 2022 | Ordinary Shares, par value EUR 0.01 per share | 21.1K | $51.83 | Direct | F1, F7 |
transaction | ST | Stock options to Buy | Options Exercise | $0 | -22K | -50% | $0.00 | 22K | Jan 3, 2022 | Ordinary Shares, par value EUR 0.01 per share | 22K | $46.93 | Direct | F1, F8 |
transaction | ST | Stock options to Buy | Options Exercise | $0 | -52.5K | -100% | $0.00* | 0 | Jan 4, 2022 | Ordinary Shares, par value EUR 0.01 per share | 52.5K | $43.16 | Direct | F1, F9 |
transaction | ST | Stock options to Buy | Options Exercise | $0 | -42.5K | -100% | $0.00* | 0 | Jan 4, 2022 | Ordinary Shares, par value EUR 0.01 per share | 42.5K | $38.96 | Direct | F1, F10 |
Id | Content |
---|---|
F1 | The transactions being reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2021. |
F2 | Includes 240,759 unvested restricted stock units, of which 152,381 are subject to performance conditions. |
F3 | Reflects the sale of an aggregate of 108,189 shares of common stock on January 3, 2022, at the weighted average sales price of $62.7635. The prices for these sales range from $62.20 to $63.38. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F4 | Represents shares held by an irrevocable family trust having a disinterested trustee for the benefit of the reporting person's spouse and children (the "Cote Family 2020 Irrevocable Trust"). |
F5 | The option grant is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2016. |
F6 | The option grant is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2018. |
F7 | The option is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2019. On the date of this transaction, 21,090 options were exercisable. |
F8 | These options are exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2020. On the date of this transaction, 21,998 options were exercisable. |
F9 | The option grant is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2015. |
F10 | The option is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2017. |